-
Something wrong with this record ?
Novel acetylcholinesterase reactivator--oxime K048--reactivation activity in vitro
K. Kuca, J. Marek, J. Karasova, M. Pohanka, J. Korabecny, H. Kalasz,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Acetylcholinesterase metabolism MeSH
- Enzyme Activation drug effects MeSH
- Antidotes pharmacology MeSH
- Chemical Warfare Agents pharmacology MeSH
- Cholinesterase Inhibitors pharmacology MeSH
- Enzyme Reactivators pharmacology MeSH
- Rats MeSH
- Humans MeSH
- Organophosphorus Compounds pharmacology MeSH
- Oximes pharmacology MeSH
- Rats, Wistar MeSH
- Pyridinium Compounds pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
A novel acetylcholinesterase (AChE) reactivator, a bispyridinium aldoxime named K048, was first synthesized in 2003. It is a promising antidote against tabun poisoning. Afterwards, other studies on several cholinesterases (ChE) of different species (humans, rats, etc.) and models (in vitro or in vivo) were conducted. We tested this oxime against nine different AChE inhibitors using in vitro tests on rat brain homogenate as source of enzyme. Our results showed that oxime K048 reached promising reactivation activity in case of all tested AChE inhibitors, except cyclosarin, at oxime concentration 10(-3) M. At a concentration of 10(-5) M, which is more common for human use, only methylchlorpyrifos-inhibited AChE was reactivated.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025782
- 003
- CZ-PrNML
- 005
- 20130213094327.0
- 007
- ta
- 008
- 120817s2010 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.2174/157340610791208709 $2 doi
- 035 __
- $a (PubMed)20402654
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kuca, Kamil $u Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. kucakam@pmfhk.cz
- 245 10
- $a Novel acetylcholinesterase reactivator--oxime K048--reactivation activity in vitro / $c K. Kuca, J. Marek, J. Karasova, M. Pohanka, J. Korabecny, H. Kalasz,
- 520 9_
- $a A novel acetylcholinesterase (AChE) reactivator, a bispyridinium aldoxime named K048, was first synthesized in 2003. It is a promising antidote against tabun poisoning. Afterwards, other studies on several cholinesterases (ChE) of different species (humans, rats, etc.) and models (in vitro or in vivo) were conducted. We tested this oxime against nine different AChE inhibitors using in vitro tests on rat brain homogenate as source of enzyme. Our results showed that oxime K048 reached promising reactivation activity in case of all tested AChE inhibitors, except cyclosarin, at oxime concentration 10(-3) M. At a concentration of 10(-5) M, which is more common for human use, only methylchlorpyrifos-inhibited AChE was reactivated.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antidota $x farmakologie $7 D000931
- 650 _2
- $a chemické bojové látky $x farmakologie $7 D002619
- 650 _2
- $a cholinesterasové inhibitory $x farmakologie $7 D002800
- 650 _2
- $a aktivace enzymů $x účinky léků $7 D004789
- 650 _2
- $a enzymové reaktivátory $x farmakologie $7 D004793
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a organofosforové sloučeniny $x farmakologie $7 D009943
- 650 _2
- $a oximy $x farmakologie $7 D010091
- 650 _2
- $a pyridinové sloučeniny $x farmakologie $7 D011726
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Marek, Jan
- 700 1_
- $a Karasova, Jana
- 700 1_
- $a Pohanka, Miroslav
- 700 1_
- $a Korabecny, Jan
- 700 1_
- $a Kalasz, Huba
- 773 0_
- $w MED00180387 $t Medicinal chemistry (Shāriqah (United Arab Emirates)) $x 1875-6638 $g Roč. 6, č. 1 (2010), s. 1-5
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20402654 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20130213094511 $b ABA008
- 999 __
- $a ok $b bmc $g 947824 $s 783128
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 6 $c 1 $d 1-5 $i 1875-6638 $m Medicinal chemistry $n Med Chem $x MED00180387
- LZP __
- $a Pubmed-20120817/10/03